Histopathology · 1998 · 37 citations · 14 references
MedicineImmunologyPathologyHepatologyHistopathologyImmunopathologyChronic Liver DiseaseHepatic PathologyHepatobiliary DiseaseHepatobiliary PathologyInterferon-based TherapyLiver DiseaseEpithelioid Cell GranulomasGranulomatous LesionsGranulomatous ReactionsHistological ResponseImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical StainingLiver Histology
AIMS: The clinicopathological significance of intrahepatic epithelioid cell granulomas in chronic hepatitis C was determined. METHOD AND RESULTS: Granulomatous lesions were surveyed in 542 liver biopsy specimens and were immunohistochemically examined. We also tested whether this lesion is a marker of response to interferon-alpha therapy in chronic hepatitis C. Granulomatous lesions in hepatic lobules and/or portal tracts were identified in 11/542 (2%) cases with chronic hepatitis C. Granulomas were positive for HLA-DR and beta 2-microglobulin, and were surrounded by T-cells. Among them, three chronic hepatitis C cases showed portal granulomas with mild biliary epithelial damage. Bile ducts showing mild epithelial damage in chronic hepatitis C were positive for beta 2-microglobulin, but negative for HLA-DR, while both antigens were frequently expressed in damaged bile ducts in primary biliary cirrhosis (PBC). All five cases of chronic hepatitis C with granulomas who had interferon-alpha therapy and were followed up and were found to have responded well. CONCLUSION: Granulomas showed the same immunohistochemical phenotypes, though the expression of HLA-DR on bile ducts in PBC but not in chronic hepatitis C suggests a different pathogenesis. Granulomas may predict a favourable response to interferon-alpha therapy in chronic hepatitis C.
14
S M Hsu, Laurence Raine, Herbert Fanger · Journal of Histochemistry & Cytochemistry · 1981 · 14.3K citations · Full text
Classification of chronic hepatitis: Diagnosis, grading and staging
Valeer Desmet, Michael A. Gerber, Jay H. Hoofnagle et al. · Hepatology · 1994 · 2.6K citations
Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa
Gary L. Davis, Luis A. Balart, Eugene R. Schiff et al. · New England Journal of Medicine · 1989 · 1.7K citations
Peter J. Scheuer, P. Ashrafzadeh, Sheila Sherlock et al. · Hepatology · 1992 · 542 citations
Medicine, Pathology, Hepatology +16